States may be on the hook for $55 billion to pay for hepatitis C treatments like Sovaldi, a new study says.» Read More
CNBC's Herb Greenberg has the story on a big battle brewing over where prescriptions are filled and how much you are going to pay, with Mark Merritt, PCMA president & CEO, and David Balto, antitrust attorney.
The Fast Money traders have the play on Limited Brands.
Deborah Weinswig, Citi analyst, defends her downgrade of WAG, on the heels of its big fight with Express Scripts, with the Fast Money traders.
Objections to Express Scripts' $29 billion plan to buy rival pharmacy benefits manager Medco Health are growing, with CNBC's Bertha Coombs.
CNBC's David Faber reports on the battle between Walgreens and pharmacy benefit manager, Express Scripts.